Rosuvastax-Drossapharm 5 mg
Rosuvastax-Drossapharm 5 mg is a medicine authorised by Swissmedic under authorisation number 69613. The authorisation holder is Drossapharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 April 2025 and the authorisation is limited until 02 April 2030. ATC code C10AA07 places the medicine in the group Lipid modifying agents.
| Authorisation number | 69613 |
|---|---|
| Name | Rosuvastax-Drossapharm 5 mg |
| Full name | Rosuvastax-Drossapharm 5 mg, Filmtabletten |
| Authorisation holder | Drossapharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C10AA07 |
| First authorisation | 03 April 2025 |
| Authorisation validity | 02 April 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rosuvastax-Drossapharm 5 mg, Filmtabletten | B | 03 April 2025 |
| 2 | Rosuvastax-Drossapharm 10 mg, Filmtabletten | B | 03 April 2025 |
| 3 | Rosuvastax-Drossapharm 20 mg, Filmtabletten | B | 03 April 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 2 | 100 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 3 | 30 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 4 | 100 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 5 | 30 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 6 | 100 | Tablette(n) | C10AA07 | 07.12.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rosuvastax-Drossapharm 5 mg authorised in Switzerland?
Yes. Rosuvastax-Drossapharm 5 mg is authorised by Swissmedic under authorisation number 69613, data as of 01 September 2026. The authorisation is limited until 02 April 2030.
Which dispensing category does Rosuvastax-Drossapharm 5 mg have?
Rosuvastax-Drossapharm 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rosuvastax-Drossapharm 5 mg?
The authorisation holder is Drossapharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.